Celltrion to Spotlight Subcutaneous (SC) Infliximab (Remsima™ SC) and Broader IBD Portfolio at UEG Week 2026

Posted on by sHq_LoGiNz

INCHEON, South Korea–(BUSINESS WIRE)– #Celltrion–Celltrion will showcase its IBD portfolio, including Remsima™ SC, at UEG Week 2026 in Barcelona from Oct. 17 to 20.

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.